NCT Number: NCT06089148
New Mammographic Techniques Versus MRI in Assessment of Breast Lesions
Value of New Mammography Techniques in Comparison to Dynamic Contrast-Enhanced MRI of the Breast in the Detection and Diagnosis of Breast lesions
Looking for future studies?
Notify MeKey information
Sex eligibility
Female
Study type
Observational
About this study
Combined use of contrast-enhanced digital mammography (CEDM), and digital breast tomosynthesis (DBT), may be a reasonable alternative to MRI.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Breast Imaging Reporting and Data System (BI-RADS) 3, 4, and 5 breast lesions.
- Clinical indication for MRI breast imaging.
- No histologically proven cancer before enrollment. Exclusion criteria
- Pregnancy or possible pregnancy. 2. History of allergy to an iodinated contrast agent. 3. Renal impairment. 4. Contraindication for MRI examination
Treatment and study plan
Primary outcomes
-
sensitivity, specificity of'tomosynthesis and contrast enhanced mammography and MRI breast are measured in assessment of breast lesions and their pre-operative assessment of breast cancer
Time frame: 1year
diagnostic
Sponsors and collaborators
Lead sponsor
Cairo University
Other
Registry information
Official study title
Value of New Mammography Techniques in Comparison to Dynamic Contrast-Enhanced MRI of the Breast in the Detection and Diagnosis of Breast Lesions
Acronym: CEDM&DBTVSMR
Important dates
- Study start
- 2015
- Primary completion
- 2016
- Study completion
- 2016
- First posted
- Oct 18, 2023
- Registry last updated
- Oct 18, 2023
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
REGENERA Implant in Localized Non-malignant Breast Lesions Treated by Excision or Lumpectomy - Long-term Follow-up
NCT05533099
Breast Diseases, Skin Diseases
Pisa, Italy
View Trial DetailsLeflunomide in Previously Treated Metastatic Triple Negative Cancers
NCT03709446
Breast Diseases, Breast Neoplasms
New York, United States
View Trial DetailsDotarem vs Gadobutrol Contrast for Breast MRI
NCT03730051
Breast Diseases, Skin Diseases
Worcester, Massachusetts, United States
View Trial DetailsThe Use of AI to Safely Reduce the Workload in Breast Cancer Screening With Mammography in Region Östergötland
NCT06187350
Artificial Intelligence, Breast Diseases
Linköping, Östergötland County, Sweden
View Trial Details